Fig. 1From: Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO)Outcomes (OS and/or EFS) in metastatic and non-metastatic IBC patients (a, b and c), EFS in TNBC patients (e), and impact of Hormone therapy and Radiotherapy (d and f). (OS: Overall survival; EFS: Event-Free Survival)Back to article page